Atea Pharmaceuticals, Inc.

Q2 2023 13F Holders

Symbol
AVIR
CUSIP
04683R106
Type
Equity
Class
COM
Num filings
139
Total reported value, excl. options
$213 M
Manager Report Date Value ($000) Shares Option Type